India Pharmaceutical & API Trade → 🇯🇵 Japan
India-Japan CEPA | USD 23B bilateral | Commission-Only Mandate Guide
VERTICAL × COUNTRY MANDATE GUIDES
All Frontier Global Nexus · Commission-Only · allfrontierglobal.com
Mandate Intelligence Summary
India Pharmaceutical & API Trade → Japan: Sell Mandate
Product categories and HS codes applicable to this vertical
FTA duty rate vs MFN duty rate: calculate savings at allfrontierglobal.com/tools/fta-savings-estimator.php
Certification requirements for Japan market: WHO-GMP, USFDA, EU-GMP
Key buyer segments in Tokyo, Osaka
Typical contract structure: annual framework, spot, quarterly indent
Japan → India: Buy Mandate
- Technology, capital goods, and specialty imports India sources from Japan
- Raw materials, commodities, and inputs required by Indian pharmaceutical & api trade sector
- Investment and services mandates in both directions
Multilateral Route Opportunity
- India → UAE (CEPA) → Japan: Duty saving and JAFZA re-export advantage
- Japan → India → ASEAN: India as hub for Japan goods reaching Southeast Asia
- India → Japan → Third Market: triangulation for specific commodities
Submit a Mandate
- All mandates in India Pharmaceutical & API Trade ↔ Japan corridor are facilitated commission-only by All Frontier Global Nexus.
- Submit at: allfrontierglobal.com/guides/vertical-country/pharma-japan.php
- Both India (Panchkula) and EU (Porto) principals active and responsive within 1 business day.
| Parameter | Detail |
|---|---|
| Vertical | Pharmaceutical & API Trade |
| Country | 🇯🇵 Japan |
| Trade Framework / FTA | India-Japan CEPA |
| Bilateral Trade Volume | USD 23B bilateral |
| Indian Export Hubs | hyderabad,pune,ahmedabad,mumbai |
| Global Buyer Cities | Tokyo, Osaka |
| Certifications Required | WHO-GMP, USFDA, EU-GMP |
| AJG Mandate Types | Sell (India→Japan), Buy (Japan→India), Bilateral, Trilateral via UAE, Multilateral |